(Q40141121)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Yiliang Yang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Shan Cen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lawrence Kleiman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

24 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

17 September 2017

365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

92-100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17459442%20AND%20SRC:MED&resulttype=core&format=json

APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Antiviral potency of APOBEC proteins does not correlate with cytidine deamination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

A quantitative assay for HIV DNA integration in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Roles of Pr55(gag) and NCp7 in tRNA(3)(Lys) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

The interaction between HIV-1 Gag and APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

DNA deamination mediates innate immunity to retroviral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

APOBEC-mediated interference with hepadnavirus production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Inhibition of hepatitis B virus replication by APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

APOBEC3G incorporation into human immunodeficiency virus type 1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

Role of Vif in human immunodeficiency virus type 1 reverse transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

7 January 2021

Primer tRNA3Lys on the viral genome exists in unextended and two-base extended forms within mature human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

7 January 2021

Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

7 January 2021

Transfer RNA into RNA tumor viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.03.022

7 January 2021